MLYS Archived Articles
Mineralys Therapeutics (NASDAQ:MLYS): A Clinical-Stage Biotech Targeting Hypertension and Related Conditions
Published on March 14, 2025
Mineralys Therapeutics, Inc. (NASDAQ:MLYS): Pioneering Targeted Therapies for Cardiorenal Diseases
Published on November 30, 2024
Mineralys Therapeutics, Inc. (NASDAQ:MLYS): A Promising Aldosterone-Targeting Approach to Cardiorenal Diseases
Published on September 24, 2024